• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Alphatec Holdings Inc.

    4/25/25 4:16:51 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email
    DEFA14A 1 atec_2025_proxy_naa_no.x.htm DEFA14A DEFA14A

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a) of the Securities

    Exchange Act of 1934 (Amendment No.)

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

    ☐ Preliminary Proxy Statement

    ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐ Definitive Proxy Statement

    ☒ Definitive Additional Materials

    ☐ Soliciting Material Pursuant to §240.14a-12

    Alphatec Holdings, Inc.

    (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒ No fee required

    ☐ Fee paid previously with preliminary materials

    ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

     


     

    img52452509_0.jpg

     

    P.O. BOX 8016, CARY, NC 27512-9903 Your vote Alphatec Holdings, Inc. Annual Meeting of Stockholders Wednesday, June 11, 2025 10:00 AM, Pacific Time ATEC Spine, Inc. 1950 Camino Vida Roble, Carlsbad, CA 92008 Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report or Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Stockholders Meeting To Be Held On June 11, 2025 For Stockholders of record as of April 16, 2025 To order paper materials, use one of the following methods. For a convenient way to view proxy materials, VOTE, and obtain directions to attend the meeting go to www.proxydocs.com/ATEC To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before June 30, 2025. Internet: www.investorelections.com/ATEC Call: 1-866-648-8133 Email: [email protected] * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Have the 12 digit control number located in the box above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA


     

    img52452509_1.jpg

     

    Copyright 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved Alphatec Holdings, Inc. Annual Meeting of Stockholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2, 3, 4 AND 5 1. To elect nine persons to our Board of Directors 1.01 Mortimer Berkowitz III 1.02 Quentin Blackford 1.03 David Demski 1.04 Karen K. McGinnis 1.05 Patrick S. Miles 1.06 David R. Pelizzon 1.07 Jeffery P. Rydin 1.08 Keith Valentine 1.09 Ward W. Woods 2. To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. 3. Approval of an amendment to our 2016 Equity Incentive Plan. 4. Approval of an amendment to our Certificate of Incorporation. 5. To approve, on an advisory basis, the compensation of our named executive officers.


    Get the next $ATEC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC

    DatePrice TargetRatingAnalyst
    10/28/2025$20.00Buy
    Stifel
    10/24/2025$19.00Overweight
    Analyst
    6/16/2025$18.00Buy
    Lake Street
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    7/8/2024$19.00Overweight
    Barclays
    2/9/2024$26.00Overweight
    Wells Fargo
    12/19/2023$16.00 → $18.00Buy
    Needham
    10/20/2023$22.00Buy
    ROTH MKM
    More analyst ratings

    $ATEC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion

    ATEC Secures Exclusive U.S. Rights to OsteoAdapt® Platform in Major Strategic Alignment Theradaptive Initiates Series B to Advance Proprietary Protein-Engineering Technology CARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ -- Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing spine surgery, and Theradaptive, Inc., a clinical-stage regenerative medicine company pioneering engineered protein therapeutics, today announced a definitive strategic partnership agreement. Concurrently, Theradaptive announced the initiation of a Series B investment round designed to accelerate the expansion of its proprietary protein-engineering platf

    1/12/26 9:30:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

    Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended December 31, 2025 Surgical Revenue $189.3M to $190.0M $686.3M to

    1/12/26 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, SALES Sponsel David sold $833,261 worth of shares (60,425 units at $13.79), decreasing direct ownership by 15% to 349,500 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/6/26 6:57:15 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    EVP, PEOPLE & CULTURE Hunsaker Craig E sold $549,536 worth of shares (37,358 units at $14.71), decreasing direct ownership by 3% to 1,173,025 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    2/4/26 7:00:06 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick sold $2,101,000 worth of shares (100,000 units at $21.01), decreasing direct ownership by 2% to 5,135,398 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    1/6/26 7:00:06 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel resumed coverage on Alphatec with a new price target

    Stifel resumed coverage of Alphatec with a rating of Buy and set a new price target of $20.00

    10/28/25 7:09:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Alphatec with a new price target

    Analyst initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

    10/24/25 8:59:42 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Lake Street resumed coverage on Alphatec with a new price target

    Lake Street resumed coverage of Alphatec with a rating of Buy and set a new price target of $18.00

    6/16/25 8:53:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    SEC Filings

    View All

    Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    1/12/26 9:10:26 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    1/5/26 4:43:59 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    11/7/25 9:10:27 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Leadership Updates

    Live Leadership Updates

    View All

    ATEC Mourns Passing of Board Member Jeffrey P. Rydin

    Alphatec Holdings, Inc. (NASDAQ:ATEC) ("ATEC"), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologies, Inc., NuVasive, Inc., and DePuy Spine, Inc. He was one of the earliest to join the ATEC turnaround effort, coming to the Company as a Special Advisor to the Board in September 2016, in which capacity he drove many of the early deci

    11/7/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Paragon 28 Appoints Dave Demski to Board of Directors

    Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

    12/11/24 9:00:00 AM ET
    $ATEC
    $FNA
    Medical/Dental Instruments
    Health Care

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care

    $ATEC
    Financials

    Live finance-specific insights

    View All

    ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook

    Full-year 2025 total revenue grew 25% to approximately $764 million Expect full-year 2026 total revenue of $890 million Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Select Financial Results   Fourth Quarter Ended December 31, 2025 Full Year Ended December 31, 2025 Surgical Revenue $189.3M to $190.0M $686.3M to

    1/12/26 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Third Quarter 2025 Financial Results on October 30, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2025 financial results on October 30, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations section of ATEC's corporate website. Dial-In To dial into the live webcast, please register at this link. Access details will be provided via email. Replay A replay of the webcast will remain available through the Investor Relations section of ATEC's corporate website for twelve month

    10/16/25 4:10:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    5/12/23 4:51:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care